Article info

Download PDFPDF
Short report
TP53 c.455C>T p.(Pro152Leu) pathogenic variant is a lower risk allele with attenuated risks of breast cancer and sarcoma

Authors

  • D Gareth Evans Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Elaine F Harkness Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • Emma R Woodward Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  1. Correspondence to D Gareth Evans, Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; gareth.evans{at}mft.nhs.uk
View Full Text

Citation

Evans DG, Harkness EF, Woodward ER
TP53 c.455C>T p.(Pro152Leu) pathogenic variant is a lower risk allele with attenuated risks of breast cancer and sarcoma

Publication history

  • Received December 30, 2022
  • Accepted March 10, 2023
  • First published April 19, 2023.
Online issue publication 
October 24, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.